Published September 3, 2025 | Version v1
Report Open

Influenza Vaccine Market Size, Trends, and Outlook 2032

Creators

Description

Global Influenza Vaccine Market Analysis

Market Size & Growth

The global influenza vaccine market is projected to grow from $8.55 billion in 2024 to $17.77 billion by 2032, at a CAGR of 9.6%. North America dominates with a 53.7% market share in 2023, valued at $4.28 billion.

Key Market Drivers

  • Rising disease prevalence: WHO reports 3-5 million severe influenza cases annually, causing 290,000-650,000 deaths globally
  • Government support: Expanding immunization programs and public health campaigns
  • R&D investments: Development of combination vaccines and new technologies
  • COVID-19 impact: Increased vaccine awareness and uptake during pandemic

Market Segments

By Type

  • Inactivated vaccines lead with 91.94% market share in 2023
  • Live attenuated vaccines growing at slower rate due to development challenges
  • mRNA vaccines emerging as promising segment with new developments

By Distribution Channel

  • Hospital & retail pharmacies: 54% market share in 2023
  • Government suppliers
  • Others

Regional Analysis

North America

  • Largest market share (53.35%) in 2023
  • Strong public health infrastructure
  • High vaccination rates
  • Presence of major manufacturers

Europe

  • Second-largest market position
  • Strong healthcare infrastructure
  • Recent developments include GSK's agreement with HERA for 85 million pandemic vaccine doses

Asia Pacific

  • Fastest-growing region
  • Large population base
  • Increasing healthcare expenditure
  • Rising government initiatives

Key Players

  1. GSK plc
  2. Sanofi
  3. AstraZeneca
  4. CSL Limited
  5. SINOVAC

Recent Developments

  • June 2024: SINOVAC announced $100 million investment in Brazil for vaccine production
  • April 2024: CDC expanded RSV vaccine recommendations for adults aged 50-59
  • February 2024: CSL and Arcturus received EU approval for KOSTAIVE mRNA COVID-19 vaccine3

Market Challenges

  • Extended vaccine production timelines (10-15 years average)
  • Complex regulatory requirements
  • High manufacturing costs
  • Cold chain storage requirements

Report-

Fortune Business Insights - Influenza Vaccine Market Size & Share | Industry Growth, 2032

https://www.fortunebusinessinsights.com/industry-reports/influenza-vaccine-market-101896

Files

Influenza Vaccine Market Size & Share.pdf

Files (449.4 kB)

Name Size Download all
md5:4c2f49275c6f79c362a4599d05b6d0dd
449.4 kB Preview Download